18 Multiple Sclerosis Clinical Trials in Seattle, WA (2026)

Q: How do I join a clinical trial in Seattle?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you.

Recruiting Multiple Sclerosis Studies in Seattle

NCT00756665Recruiting

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close mo...

Seattle, WA3,000 participantsUniversity of Washington

View Study Details

NCT06441617Recruiting

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

CAFE-MS will assess the effectiveness of two online programs for fatigue in multiple sclerosis (MS). Although they differ, both of these online programs contain information about MS and fatigue intend...

Seattle, WANA2,000 participantsAccelerated Cure Project for Multiple Sclerosis

View Study Details

NCT01538056Recruiting

Physician Modified Endovascular Grafts

The primary objectives of this study are to determine whether physician modified endovascular grafts (PMEG) and specified company manufactured investigational devices are a safe and effective method o...

Seattle, WANA500 participantsUniversity of Washington

View Study Details

NCT04495790Recruiting

AIMS Cancer Outcomes Study

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative...

Seattle, WA500 participantsAdvanced Integrative Medical Science Institute

View Study Details

NCT02701244Recruiting

A Registry Study of Breast Microseed Treatment

For women diagnosed with early stage breast cancer, lumpectomy followed by radiation is a common treatment option. Radiation treatment is typically delivered to the whole breast, five times per week, ...

Seattle, WA420 participantsConcure Oncology-Breast Microseed Inc.

View Study Details

NCT06663319Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

The purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) and best way to take (optimal route of administration) JNJ-89402638 and to determine the safety of JNJ-894026...

Seattle, WAPHASE1260 participantsJanssen Research & Development, LLC

View Study Details

NCT06693011Recruiting

Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

The goal of this clinical trial is to collect additional data to demonstrate if the Contour Neurovascular System (CNS) is a safe and effective treatment of wide-necked, saccular, intracranial aneurysm...

Seattle, WANA250 participantsCerus Endovascular, Inc.

View Study Details

NCT04794322Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

The study aims to develop a test for early detection of ovarian cancer using DNA from a growth involving the ovary found in a washing of the uterus (womb), and proteins found in the blood. The samples...

Seattle, WA250 participantsMassachusetts General Hospital

View Study Details

NCT05004051Recruiting

ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA

This is a Prospective Registry study to collect imaging and clinical data both on patients with aortic aneurysm disease undergoing serial monitoring and on patients pre and post-endovascular repair, u...

Seattle, WA200 participantsViTAA Medical Solutions

View Study Details

NCT07074886Recruiting

A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

The main purpose of this study is to assess the bioequivalence of ocrelizumab SC test formulation to the marketed ocrelizumab SC reference formulation in participants with either relapsing multiple sc...

Seattle, WAPHASE2182 participantsHoffmann-La Roche

View Study Details

NCT07082920Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the study and to determine h...

Seattle, WAPHASE1140 participantsJanssen Research & Development, LLC

View Study Details

NCT05958316Recruiting

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors...

Seattle, WANA126 participantsVirginia Commonwealth University

View Study Details

NCT06809192Recruiting

Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

This randomized controlled factorial trial will examine whether and how relaxation training, behavioral activation, and cognitive therapy improve fatigue and functioning in fatigued adults living with...

Seattle, WANA112 participantsUniversity of Washington

View Study Details

NCT06270641Recruiting

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insuf...

Seattle, WANA106 participantsUniversity of Washington

View Study Details

NCT06796504Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients with patients diagnosed with relapsing-remitting multiple sc...

Seattle, WANA60 participantsSetPoint Medical Corporation

View Study Details

NCT07224373Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multip...

Seattle, WAPHASE124 participantsAstraZeneca

View Study Details

NCT07026877Recruiting

Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA

The goal of this clinical trial is to learn if the Fenestrated TREO Stent-Graft System works to treat abdominal aneurysms in adults. An abdominal aneurysm is a bulge in the main blood vessel (the aort...

Seattle, WANA20 participantsBolton Medical

View Study Details

NCT06552611Recruiting

Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis

Current disease-modifying therapies for multiple sclerosis (MS) aim to prevent the development of new lesions; unfortunately, no current FDA-approved therapies promote central nervous system (CNS) rep...

Seattle, WAPHASE14 participantsUniversity of Washington

View Study Details

About Multiple Sclerosis Clinical Trials in Seattle

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 18 multiple sclerosis clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 8,154 participants. Research is being sponsored by University of Washington, Accelerated Cure Project for Multiple Sclerosis, Advanced Integrative Medical Science Institute and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Seattle — FAQ

Are there multiple sclerosis clinical trials in Seattle?

Yes, there are 18 multiple sclerosis clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 18 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 17, 2026 from ClinicalTrials.gov